The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://heathgklw824882.eqnextwiki.com/5440330/retatrutide_vs_tirzepatide_a_comparative_analysis